All excellent points ajohn.....and let me just add, if you remove the socioeconomic factors at play here, all fundamentals with RXMD point to a massive correction to the upside very soon, with nothing that would indicate any further downside. Take just a few of the pro's/con's for example:
Pro's
1) 2 consecutive quarters of full operational profitability,
with future quarters all but guaranteed.
2) Currently generating an avg of 1.5M in revenue MONTHLY,
with the robotic dispensing system installed and
being readied for operation as we speak. Robotic
dispensing system will essentially double script fills
and monthly revenues with zero additional overhead.
3) Audited financials to be incorporated any quarter.
4) M&A activities currently under way, with the
engagement of Monarch Bay. RXMD pursuing economies of
scale.
5) RXMD goal to uplist to NASDAQ in near future.
6) Currently licensed in 9 states, with more to come.
Con's
1) Currently trading on the Pinks (goal to change this).
2) Unaudited financials (audited coming any quarter).
I'm sure I'm missing some pro's, but as you can see the only two con's that I'm aware of are already on management's list to correct, and soon!
So, to sum it up, LONG is the ONLY place to be with this one!!!!
News 
Market Data 
Discover 
